What the research examined
Experimental work examined the tripeptide KPV in inflammatory systems. A study of intestinal cells and mouse colitis investigated PepT1-associated uptake and changes in inflammatory signaling, including NF-kappaB and MAPK pathways.
How to interpret the findings
Cellular pathway measurements and mouse colitis are preclinical evidence. They do not establish efficacy in inflammatory bowel disease in people. Related melanocortin peptides should not be assumed to have identical receptor interactions or effects.
Research literature
- Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides.
The Journal of pharmacology and experimental therapeutics · 2003 · PMID 12750433 - PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation.
Gastroenterology · 2008 · PMID 18061177
Links open the indexed paper records. Summaries are based on those records and their available abstracts, not a systematic review or a full-text appraisal of every study.